Impact of PGE1 on cyclosporine A induced up-regulation of TGF-β1, its receptors, and related matrix production in cultured mesangial cells

被引:9
作者
Dell, K [1 ]
Böhler, T [1 ]
Gaedeke, J [1 ]
Budde, K [1 ]
Neumayer, HH [1 ]
Waiser, J [1 ]
机构
[1] Humboldt Univ, Hosp Charite, Dept Internal Med Nephrol, D-10117 Berlin, Germany
关键词
cyclosporine A; glomerulosclerosis; mesangial cells; prostaglandin E-1; transforming growth factor-beta;
D O I
10.1016/S1043-4666(03)00151-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor-beta1 (TGF-beta1) plays a major role in cyclosporine A (CsA) induced glomerulosclerosis. We have recently shown that CsA up-regulates the expression of TGF-beta1 and its receptors type I (TbetaR-I) and type 11 (TbetaR-II) in rat mesangial cells (MCs). Prostaglandins of the E series (PGEs) are known to exert substantial anti-fibrotic effects. Here, we assessed the effect of PGE(1) on CsA induced up-regulation of TGF-beta1, TbetaR-I, TbetaR-II and related matrix production in MCs. Co-incubation with PGE(1) reduced CsA induced up-regulation of TGF-beta1 and TbetaR-II at the mRNA and protein level. Alike, PGE(1) reduced TbetaR-I protein expression, which is posttranscriptionally up-regulated by CsA. Whereas a low PGE1 concentration decreased CsA induced production of fibronectin (FN) and plasminogen activator inhibitor type-1 (PAI-1), a higher PGE(1) concentration did not change FN production, but further increased PAI-1 production. In vivo studies will show, whether treatment with PGE(1) analogues will be useful in preventing CsA induced glomerulosclerosis. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:189 / 193
页数:5
相关论文
共 15 条
[1]   Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy [J].
Bennett, WM ;
DeMattos, A ;
Meyer, MM ;
Andoh, T ;
Barry, JM .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1089-1100
[2]   RAT MESANGIAL CELLS PRODUCE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [J].
BUDDE, K ;
COLEMAN, DL ;
LACY, J ;
STERZEL, RB .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (06) :F1065-F1078
[3]   THE EFFECT OF CYCLOSPORINE ON AGONIST-STIMULATED GLOMERULAR AND MESANGIAL CELL VASODILATORY PROSTAGLANDIN PRODUCTION [J].
BUNKE, M ;
WILDER, L ;
MARTIN, A .
TRANSPLANTATION, 1991, 52 (04) :718-722
[4]   The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival2 [J].
Gjertson, DW ;
Cecka, JM ;
Terasaki, PI .
TRANSPLANTATION, 1995, 60 (12) :1384-1388
[5]   Transforming growth factor (TGF)-β mimics and anti-TGF-β antibody abrogates the in vivo effects of cyclosporine -: Demonstration of a direct role of TGF-β in immunosuppression and nephrotoxicity of cyclosporine [J].
Khanna, AK ;
Cairns, VR ;
Becker, CG ;
Hosenpud, JD .
TRANSPLANTATION, 1999, 67 (06) :882-889
[6]   TGF-β:: A link between immunosuppression, nephrotoxicity, and CsA [J].
Khanna, AK ;
Cairns, VR ;
Becker, CG ;
Hosenpud, JD .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) :944-945
[7]  
MIHATSCH M, 1995, KIDNEY INT, V48, P63
[8]  
OPELZ G, 1992, TRANSPLANT P, V24, P2342
[9]   Medical progress - Strategies to improve long-term outcomes after renal transplantation [J].
Pascual, M ;
Theruvath, T ;
Kawai, T ;
Tolkoff-Rubin, N ;
Cosimi, AB .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (08) :580-590
[10]  
Pricci F, 1996, DIABETOLOGIA, V39, P1055